Treatment outcomes in retinoblastoma and the effect of tumor topography.

Autor: Kheir WJ; Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon., Slim A; Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon., Hadi DE; Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon., Bechara E; Department of Pediatrics and Adolescent Medicine and Children's Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Borghol R; Department of Pediatrics and Adolescent Medicine and Children's Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Noun D; Department of Pediatrics and Adolescent Medicine and Children's Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Al-Haddad C; Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
Jazyk: angličtina
Zdroj: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31334. Date of Electronic Publication: 2024 Sep 17.
DOI: 10.1002/pbc.31334
Abstrakt: Background: Retinoblastoma, the most common intraocular malignancy in children, has high fatality rates if untreated. It is crucial to monitor treatment effectiveness and explore factors influencing favorable outcomes. Our study aims to examine how tumor location impacts the response to standard treatments and the achievement of favorable outcomes among retinoblastoma patients, while controlling for other tumor-related factors.
Methods: This retrospective study analyzed medical records of retinoblastoma patients from November 2012 to December 2022 enrolled in the retinoblastoma program at the Children's Cancer Center of Lebanon (established in collaboration with St.y Jude Children's Research Hospital, Memphis, TN). Data were extracted from the electronic chart reviews and operative reports of examinations under anesthesia (EUAs), and included patient's demographics, tumor characteristics (size, location), and treatment parameters (treatment type, resolution, recurrence).
Results: The study included 42 patients with retinoblastoma, with a total of 57 eyes and 115 tumors/lesions. The median age at diagnosis was 12 months (range: 2-36 months). Among the patients, 26 (61.9%) were males and 16 (38.1%) were females. A minority of patients (21.4%) presented with unilateral involvement, whereas the majority (78.6%) had bilateral involvement. The locations of retinoblastoma lesions were distributed as follows: optic nerve (4.4%), macula (19.1%), superior (16.5%), inferior (17.4%), nasal (27.8%), and temporal (14.8%). Resolution rate tended to be highest for tumors close to optic nerve and temporal lesions, but no statistical significance was attained (p = .45). Macular lesions tended to have the fastest resolution, but again not significantly (p = .5). Multiple logistic regression revealed that the odds for resolution of tumor was not significantly associated with tumor size (p = .57) or location (p = .52).
Conclusion: Location of retinoblastoma lesions was not directly associated with recurrence-free resolution in our cohort. Further research in large retinoblastoma databases is needed to explore the association of tumor characteristics with recurrence and the need for secondary therapeutic interventions.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: